Fundz

Pluristyx closed a funding round led by BioLife Solutions and BroadOak Capital Partners to expand its product portfolio and operations.

PRIVATEJul 28, 2025

Round Type

Funding Round

SeattleBiotechnology

Investors

BioLife SolutionsBroadOak Capital Partners

Description

Pluristyx announced the successful close of a funding round to enhance its inventory with advanced cell lines and support its PluriForm™ kit. BioLife Solutions and BroadOak Capital Partners led the investment, affirming the company's vision. The newly raised capital will aid in commercialization and distribution of innovative stem cell-derived therapies. CEO Benjamin Fryer expressed excitement over the backing from industry leaders.

Quick answer

Pluristyx raised an undisclosed amount in a Funding Round round, dated July 28, 2025. Investors: BioLife Solutions and BroadOak Capital Partners. Pluristyx is based in Seattle, Washington, United States.

How much did Pluristyx raise?
Pluristyx raised an undisclosed amount in a Funding Round round on July 28, 2025.
Who invested in Pluristyx?
BioLife Solutions and BroadOak Capital Partners are named as investors in this round.
What does Pluristyx do?
Pluristyx is a pioneering company at the forefront of stem cell technologies.
Where is Pluristyx based and how big is it?
Pluristyx is based in Seattle, Washington, United States. Fundz records about 17 employees.
Who are the decision-makers at Pluristyx?
Fundz holds 1 contact at Pluristyx, including the Chief Operating Officer and Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Pluristyx that raised within 45 days of this round, from Fundz verified event records.

  • OpenHealth Technologies raised $3M (Seed) on September 11, 2025.
  • Sophont raised $9.2M (Seed) on September 11, 2025.
  • Biokraft raised $227K (Pre-Seed) on September 11, 2025.
  • Noxilizer raised $30M (Funding Round) on September 10, 2025.
  • Kriya Therapeutics raised $900M (Funding Round) on September 10, 2025.
  • CUTISS raised $68M (Series C) on September 10, 2025.

Who to call at Pluristyx, and when

A new round usually means Pluristyx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pluristyx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pluristyx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pluristyx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pluristyx

Location

Seattle, Washington, United States

About

Pluristyx is a pioneering company at the forefront of stem cell technologies. With a mission to revolutionize the field of regenerative medicine, Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies. The company's proprietary platform, panCELLa, represents a transformative leap in stem cell research, offering enhanced freedom to operate and unparalleled potential for medical advancements at a significantly accelerated timeline. Operating from two cutting-edge North American sites, Pluristyx is dedicated to driving progress and innovation in the realm of stem cell therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pluristyx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJason, Chief Operating Officer and Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pluristyx's next move

See what Strategic adds

Pluristyx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.